Patents Assigned to Xiyuan Hospital Affiliated to China Academy of TCM.
  • Patent number: 7122214
    Abstract: Rhizoma Drynariae extract (RDE) is used as therapeutical agent or in the preparation for Osteoporosis, which is characterized in containing over 30 percent of total flavonoids. Furthermore naringin contained in flavonoids is more than 30 percent and less than 100 percent. The RDE is applied for the therapy of osteoporosis or used for producing drugs treating osteoporosis. And methods of extracting the same are also related.
    Type: Grant
    Filed: December 29, 2000
    Date of Patent: October 17, 2006
    Assignees: Qihuang Pharmaceutical Technology and Investment Co., Ltd., Xiyuan Hospital Affiliated to China Academy of TCM.
    Inventor: Yanming Xie